{"id":811426,"date":"2025-02-11T08:11:00","date_gmt":"2025-02-11T13:11:00","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\/"},"modified":"2025-02-11T08:11:00","modified_gmt":"2025-02-11T13:11:00","slug":"pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\/","title":{"rendered":"PMV Pharmaceuticals to Participate at Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">PRINCETON, N.J., Feb.  11, 2025  (GLOBE NEWSWIRE) &#8212; PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that David H. Mack, Ph.D., President and Chief Executive Officer and Deepika Jalota, Pharm. D., Chief Development Officer, will participate at the following investor conferences. Management will also participate in one-on-one investor meetings.<\/p>\n<p align=\"justify\">\n        <strong>Oppenheimer 35<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Healthcare Life Sciences Conference <\/strong><br \/>\n        <br \/>Date: Wednesday, February 12, 2025<br \/>Time: 12:40 PM EST<\/p>\n<p>\n        <strong>TD Cowen 45<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Health Care Conference <\/strong><br \/>\n        <br \/>Date: Tuesday, March 4, 2025<br \/>Time: 3:10 PM EST<\/p>\n<p align=\"justify\">A live audio webcast of the events will be available online at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=psxFVkVZsqVaSTgFkRnmwKn2QTwD77enrhBI96h942dyA7MWP_-8kYjGxqIQM6F99fzO_s5VjytVXnlUZ1FhciyvqmUpLMvo_Gag7TKIZOEdXMHAaE6-bvcfXVRsqtT6CrpgSGZAs9Uhr8TWx0s_mzoAVNSepa32YiMXt_qFVwvM4xwRXdKxRSSlBpHjxezeZ-_PHNoTgsSfRPunG3KDdBO1KQQ7TQPmWYfZCsHLTxvvc6fMocQxuEki-MNQQJAp8gG66GNMvvvlfCp9eJ8njwcvedryCqBPuGG2nKXhxcBSBxoEIbQg5if8lWyPICrtkovIIlkJLHZVTIx6A7CW8A==\" rel=\"nofollow\" target=\"_blank\">Events &amp; Presentations<\/a>. An archived replay of the events will be available for 90 days following the webcast at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=psxFVkVZsqVaSTgFkRnmwKn2QTwD77enrhBI96h942cWWG4zs1Uz9BvJJ4qfAzYi92TEitR5rNciaeUim_UvBOIwsoY-BxVNTVP0Xxyvjdc1OlQPwjYx92IC6h7i094NnCGG9wzXxNGK9cYs7uYiSE_FHKdayvTXBGntHa1UOGj38N94gyuCigse-hQhQek1gvlkNsQkDUdp0XU2WbeWFxPAgTvVlRAMF222UoXt08IiEMyYTbmvatcXIm2bV9BLy69LacDXswaB5R5B-es45x0fyh_iFH2tkthPifUB-GwnfoSfWbChPekwG3_CgQ2eI3cB8LCJFPWPdVZQyNANUg==\" rel=\"nofollow\" target=\"_blank\">Events &amp; Presentations<\/a>.<\/p>\n<p>\n        <strong>About PMV Pharma<\/strong>\n      <\/p>\n<p align=\"justify\">PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53. TP53 mutations are found in approximately half of all cancers. Our co-founder, Dr. Arnold Levine, established the field of p53 biology when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize more than four decades of p53 biology, PMV Pharma combines unique biological understanding with a pharmaceutical development focus. PMV Pharma is headquartered in Princeton, New Jersey. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wrMasxdpl9XtCYLCOr7MQEKmwENy1mgNJA0qiUZXKHAS5k3Dtk3l07zbOLVJkFgE7q5u_4_75e0H5XfiEZ6grQuQyt0oFQPHRE8uGe3u-jk=\" rel=\"nofollow\" target=\"_blank\">www.pmvpharma.com<\/a>.<\/p>\n<p>\n        <strong>Investors Contact:<\/strong><br \/>\n        <br \/>Tim Smith<br \/>Senior Vice President, Head of Corporate Development and Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6nxuCC6k5O7jqhGTPVirjOjC11gXVnrYjEOTKuWEAMfsA50D2o-XsqlRKwFY-4KOp8jRTVRnezFx4N6N2hPN3KrprB1Bb3YvnrTdA0_JyFc=\" rel=\"nofollow\" target=\"_blank\">investors@pmvpharma.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Kathy Vincent<br \/>Greig Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1FeoFiL8Nud2HZSdb_G97Elr5pEChkRLIV4Bflo8-mjRSPp8YyJcS7zv-ATin-YZ9-ZqG8ElFgVpkjeVcjpj05cBcNfPmlsDvR0Lvhr21JuCOUMnKHgmJKotYVJQMeyQ\" rel=\"nofollow\" target=\"_blank\">kathy@greigcommunications.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NTk1MSM2NzQ0MTAzIzIxOTM2MTE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NTI2YTE4NmQtY2NiZS00MzE3LWEwM2QtMGY0NWUzOWY4YTYzLTEyMDUxNjQ=\/tiny\/PMV-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PRINCETON, N.J., Feb. 11, 2025 (GLOBE NEWSWIRE) &#8212; PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that David H. Mack, Ph.D., President and Chief Executive Officer and Deepika Jalota, Pharm. D., Chief Development Officer, will participate at the following investor conferences. Management will also participate in one-on-one investor meetings. Oppenheimer 35 th Annual Healthcare Life Sciences Conference Date: Wednesday, February 12, 2025Time: 12:40 PM EST TD Cowen 45 th Annual Health Care Conference Date: Tuesday, March 4, 2025Time: 3:10 PM EST A live audio webcast of the events will be available online at\u00a0Events &amp; Presentations. An archived replay of the events will be available for &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;PMV Pharmaceuticals to Participate at Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-811426","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PMV Pharmaceuticals to Participate at Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PMV Pharmaceuticals to Participate at Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PRINCETON, N.J., Feb. 11, 2025 (GLOBE NEWSWIRE) &#8212; PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that David H. Mack, Ph.D., President and Chief Executive Officer and Deepika Jalota, Pharm. D., Chief Development Officer, will participate at the following investor conferences. Management will also participate in one-on-one investor meetings. Oppenheimer 35 th Annual Healthcare Life Sciences Conference Date: Wednesday, February 12, 2025Time: 12:40 PM EST TD Cowen 45 th Annual Health Care Conference Date: Tuesday, March 4, 2025Time: 3:10 PM EST A live audio webcast of the events will be available online at\u00a0Events &amp; Presentations. An archived replay of the events will be available for &hellip; Continue reading &quot;PMV Pharmaceuticals to Participate at Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-11T13:11:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NTk1MSM2NzQ0MTAzIzIxOTM2MTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"PMV Pharmaceuticals to Participate at Upcoming Investor Conferences\",\"datePublished\":\"2025-02-11T13:11:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\\\/\"},\"wordCount\":247,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NTk1MSM2NzQ0MTAzIzIxOTM2MTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\\\/\",\"name\":\"PMV Pharmaceuticals to Participate at Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NTk1MSM2NzQ0MTAzIzIxOTM2MTE=\",\"datePublished\":\"2025-02-11T13:11:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NTk1MSM2NzQ0MTAzIzIxOTM2MTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NTk1MSM2NzQ0MTAzIzIxOTM2MTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PMV Pharmaceuticals to Participate at Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PMV Pharmaceuticals to Participate at Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"PMV Pharmaceuticals to Participate at Upcoming Investor Conferences - Market Newsdesk","og_description":"PRINCETON, N.J., Feb. 11, 2025 (GLOBE NEWSWIRE) &#8212; PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that David H. Mack, Ph.D., President and Chief Executive Officer and Deepika Jalota, Pharm. D., Chief Development Officer, will participate at the following investor conferences. Management will also participate in one-on-one investor meetings. Oppenheimer 35 th Annual Healthcare Life Sciences Conference Date: Wednesday, February 12, 2025Time: 12:40 PM EST TD Cowen 45 th Annual Health Care Conference Date: Tuesday, March 4, 2025Time: 3:10 PM EST A live audio webcast of the events will be available online at\u00a0Events &amp; Presentations. An archived replay of the events will be available for &hellip; Continue reading \"PMV Pharmaceuticals to Participate at Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-11T13:11:00+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NTk1MSM2NzQ0MTAzIzIxOTM2MTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"PMV Pharmaceuticals to Participate at Upcoming Investor Conferences","datePublished":"2025-02-11T13:11:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\/"},"wordCount":247,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NTk1MSM2NzQ0MTAzIzIxOTM2MTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\/","name":"PMV Pharmaceuticals to Participate at Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NTk1MSM2NzQ0MTAzIzIxOTM2MTE=","datePublished":"2025-02-11T13:11:00+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NTk1MSM2NzQ0MTAzIzIxOTM2MTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NTk1MSM2NzQ0MTAzIzIxOTM2MTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"PMV Pharmaceuticals to Participate at Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/811426","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=811426"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/811426\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=811426"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=811426"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=811426"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}